Literature DB >> 17112622

Occult hepatitis B virus infection.

Giovanni Raimondo1, Teresa Pollicino, Irene Cacciola, Giovanni Squadrito.   

Abstract

The persistence of hepatitis B virus (HBV) genomes in HBV surface antigen (HBsAg) negative individuals is termed occult HBV infection. Occult HBV status is associated in some cases with mutant viruses undetectable by HBsAg assays, but more frequently it is due to a strong suppression of viral replication and gene expression. Occult HBV infection is an entity with world-wide diffusion, although the available data of prevalence in various categories of individuals are often contrasting because of the different sensitivity and specificity of the methods used for its detection in many studies. Occult HBV may impact in several different clinical contexts, including the transmission of the infection by blood transfusion or organ transplantation and its acute reactivation when an immunosuppressive status occurs. Moreover, much evidence suggests that it can favour the progression of liver fibrosis and above all the development of hepatocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17112622     DOI: 10.1016/j.jhep.2006.10.007

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  139 in total

1.  Molecular characterization of occult and overt hepatitis B (HBV) infection in an HIV-infected person with reactivation of HBV after antiretroviral treatment interruption.

Authors:  S Bagaglio; L Porrino; A Lazzarin; G Morsica
Journal:  Infection       Date:  2010-06-09       Impact factor: 3.553

2.  Occult hepatitis B in blood donors: a description of two cases.

Authors:  Ciro Capezzuto; Eva Franchi; Simona Urbani; Luisa Romanò; Massimo Franchini
Journal:  Blood Transfus       Date:  2010-10       Impact factor: 3.443

Review 3.  Occult hepatitis B virus co-infection in human immunodeficiency virus-positive patients: A review of prevalence, diagnosis and clinical significance.

Authors:  Angelica Maldonado-Rodriguez; Ana Maria Cevallos; Othon Rojas-Montes; Karina Enriquez-Navarro; Ma Teresa Alvarez-Muñoz; Rosalia Lira
Journal:  World J Hepatol       Date:  2015-02-27

4.  Occult hepatitis B virus infection in children born to HBsAg-positive mothers after neonatal passive-active immunoprophylaxis.

Authors:  Hanan Foaud; Sahar Maklad; Faten Mahmoud; Hanaa El-Karaksy
Journal:  Infection       Date:  2015-02-10       Impact factor: 3.553

5.  Improved method for rapid and efficient determination of genome replication and protein expression of clinical hepatitis B virus isolates.

Authors:  Yanli Qin; Jiming Zhang; Tamako Garcia; Kiyoaki Ito; Danielle Gutelius; Jisu Li; Jack Wands; Shuping Tong
Journal:  J Clin Microbiol       Date:  2011-02-02       Impact factor: 5.948

Review 6.  Incidence and risk factors for hepatocellular carcinoma in primary biliary cirrhosis.

Authors:  Guanghua Rong; Hong Wang; Christopher L Bowlus; Chunping Wang; Yinying Lu; Zhen Zeng; Jianhui Qu; Min Lou; Yan Chen; Linjing An; Yongping Yang; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

7.  Development of occult hepatitis B viral infection in pregnancy: implications for antenatal screening in women from endemic areas.

Authors:  Philip Chang; Jeffrey Tu; Antony Chesterman; Robert Kim; Peter Robertson; William D Rawlinson; Stephen M Riordan
Journal:  Obstet Med       Date:  2010-09-17

8.  Management of hepatitis B virus reactivation in patients with hematological malignancies treated with chemotherapy.

Authors:  D Francisci; F Falcinelli; E Schiaroli; M Capponi; B Belfiori; L Flenghi; F Baldelli
Journal:  Infection       Date:  2009-11-10       Impact factor: 3.553

9.  Testing for hepatitis B infection in prospective chemotherapy patients: a retrospective study.

Authors:  Ying Wang; Xin-Mei Luo; Dan Yang; Jie Zhang; Hong-Yu Zhuo; Jian Zhang; Yu Jiang
Journal:  World J Gastroenterol       Date:  2013-02-14       Impact factor: 5.742

10.  Limited infection with occult hepatitis B virus in drug users in the USA.

Authors:  Jason T Blackard; Christina M Martin; Satarupa Sengupta; Janet Forrester
Journal:  Hepatol Res       Date:  2012-08-22       Impact factor: 4.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.